[HTML] springer.com

[HTML][HTML] Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

I Roberts, M Wright Muelas, JM Taylor, AS Davison… - Metabolomics, 2022 - Springer
Introduction The diagnosis of COVID-19 is normally based on the qualitative detection of
viral nucleic acid sequences. Properties of the host response are not measured but are key …
被引用次数：88 相关文章

Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu… - Metabolomics, 2022 - orbit.dtu.dk
Objectives: Here we provide a well-powered, untargeted metabolomics assessment of 120
COVID-19 patient samples acquired at hospital admission. The study aims to predict the …

Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

R Ivayla, MM Wright, JM Taylor, AS Davison… - …, 2022 - search.proquest.com
Objectives Here we provide a well-powered, untargeted metabolomics assessment of 120
COVID-19 patient samples acquired at hospital admission. The study aims to predict the …
[PDF] archive.org

[PDF][PDF] Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.

I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu… - scholar.archive.org
The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic
acid sequences. Properties of the host response are not measured but are key in …

Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu… - medRxiv, 2020 - medrxiv.org
The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic
acid sequences. Properties of the host response are not measured but are key in …
[PDF] core.ac.uk

[PDF][PDF] Untargeted metabolomics of COVID‑19 patient serum reveals potential prognostic markers of both severity and outcome

I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu… - Metabolomics, 2022 - core.ac.uk
Introduction The diagnosis of COVID-19 is normally based on the qualitative detection of
viral nucleic acid sequences. Properties of the host response are not measured but are key …

Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.

I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu… - 2020 - pesquisa.bvsalud.org
The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic
acid sequences. Properties of the host response are not measured but are key in …
[HTML] europepmc.org

[HTML][HTML] Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu… - 2020 - europepmc.org
The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic
acid sequences. Properties of the host response are not measured but are key in …

Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

I Roberts, MW Muelas, JM Taylor… - … : Official journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction The diagnosis of COVID-19 is normally based on the qualitative detection of
viral nucleic acid sequences. Properties of the host response are not measured but are key …
[PDF] researchgate.net

[PDF][PDF] Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.

I Roberts, MW Muelas, JM Taylor, AS Davison, Y Xu… - researchgate.net
The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic
acid sequences. Properties of the host response are not measured but are key in …